Investigating distress levels in patients with metastatic spine disease undergoing surgical intervention.
Date
2025-05
Journal Title
Journal ISSN
Volume Title
Repository Usage Stats
views
downloads
Citation Stats
Attention Stats
Abstract
Objective
Cancer patients often experience high levels of distress, which are particularly pronounced in the perioperative period. However, there is a dearth of research on distress rates in patients with metastatic spine disease (MSD). This study aims to assess pre- and postoperative distress levels in patients with MSD undergoing surgical intervention, as well as the association between distress and sociodemographic factors.Methods
The authors retrospectively queried electronic medical records from a single institution for demographic and clinical data on patients with MSD who underwent surgical intervention between 2015 and 2023. Data included pre- (within 30 days of surgery) and postoperative (within 30 and 90 days of surgery) National Comprehensive Cancer Network's distress thermometer (NCCN-DT) scores. The proportion of patients with clinically significant distress (DT score ≥ 4) at each time point was examined, as well as changes between baseline distress and distress 30 days postoperatively. The association between clinically significant distress and sex, age, race/ethnicity, and marital status was assessed. A p value < 0.05 was considered significant.Results
The study identified 265 patients with complete NCCN-DT questionnaires. Nearly half (47.5%) of the patients were female, with 66.0% identifying as Caucasian/White. The mean (± standard deviation) age at surgery was 61.4 ± 12.1 years. Preoperatively, the mean distress score was 3.6 ± 3.1 (range 0-10), with 89 (46.4%) of 192 patients reporting moderate to severe distress (DT ≥ 4). The mean distress score at 30 days postoperatively was 3.2 ± 3.0 (range 0-10), with 43.8% of patients reporting moderate to severe distress. At 90 days postoperatively, the mean distress score was 2.3 ± 2.5 (range 0-9) with 26.6% of patients reporting moderate to severe levels. Non-White patients had significantly higher preoperative distress than their White counterparts (p = 0.03).Conclusions
Distress is a common experience among patients with MSD undergoing surgical intervention. Preoperatively, nearly half of these patients report moderate to severe distress, with distress levels remaining elevated through the 1st month after surgery. These findings highlight the critical need for timely psychosocial interventions to address distress at key stages of the surgical process. Race-based differences in distress rates emphasize the importance of developing targeted support strategies for more vulnerable groups.Type
Department
Description
Provenance
Subjects
Citation
Permalink
Published Version (Please cite this version)
Publication Info
Rowe, Dana G, Joshua Woo, Ellen O'Callaghan, Connor Barrett, Emily J Luo, Tanner J Zachem, Tara Dalton, Michael Goodin, et al. (2025). Investigating distress levels in patients with metastatic spine disease undergoing surgical intervention. Neurosurgical focus, 58(5). p. E15. 10.3171/2025.2.focus24963 Retrieved from https://hdl.handle.net/10161/34363.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
Scholars@Duke
Tanner Zachem
Margaret Johnson
I am a neuro-oncologist, neurologist, and palliative care physician at the Preston Robert Tisch Brain Tumor Center. I also provide neuro-oncology expertise for the National Tele-Oncology Program and National Precision Oncology Program at the Veteran's Health Administration. My clinical and research interests encompass supportive care and palliative care with a special interest in older adults with brain tumors. The incidence of malignant brain tumors like glioblastoma and non-malignant tumors like meningioma affect aging populations and it is crucial to be able to provide better care for these patients.
Melissa Maria Erickson
I am a spine surgeon who provides surgical management of cervical, thoracic and lumbar spine conditions, including cervical myelopathy, herniated discs, deformity, stenosis, tumor and trauma. I provide both minimally invasive procedures as well as traditional surgical techniques.
Courtney Rory Goodwin
Associate Professor of Neurosurgery, Radiation Oncology, Orthopedic Surgery.
Director of Spine Oncology,
Associate Residency Program Director
Third Year Study Program Director Neurosciences, Duke University School of Medicine
Director of Spine Metastasis, Duke Center for Brain and Spine Metastasis, Department of Neurosurgery
Duke Cancer Institute, Duke University Medical Center
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.
